Vasquez Nicki — SEC Form 4 filings
SEC reporting owner CIK 1877585. 1 Form 4 filing on record with FilingPulse; latest filed 2024-01-31.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2024-01-31 to 2024-01-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 12,185 shares, $60,925 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: sale of 12,185 shares @ $5.00 ($60,925) in SUTRO BIOPHARMA, INC., filed 2024-01-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUTRO BIOPHARMA, INC. (STRO) | CHIEF PORT. STRAT & ALNCE OFCR | 1 | — | 1 leg · 12,185 sh · $60,925 | 3 |
Form 4 filings — Vasquez Nicki
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-31 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Sale (S): 12,185 @ $5 · Option exercise (M): 2,500 @ $0 · Tax withholding (F): 1,024 @ $4.99 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1877585 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →